Top Calls
|
||
|
||
Company Update � Bumi Armada (ADD,
downgrade)
Bright prospect is partly clouded by lower accounting profit Bumi Armada adopted a new accounting treatment for its large projects and the group now evaluates its new FPSO contracts on a case-by-case basis where longer tenured, large-scale FPSO projects will be treated as a financing lease. We have lowered our 2014-16E EPS by 29-33% to account for the changes in accounting treatment. However, we note that the changes are accounting in nature with no impact to the underlying cash flow and project IRR. We are switching our valuation methodology from PER multiple to sum-of-the-parts (�SOTP�) and value Bumi Armada at RM4.17 (from RM4.50). Downgrade to ADD (from BUY) in view of the lower upside potential. Notwithstanding our earnings, TP and rating cut, we continue to like Bumi Armada for its: (i) strong earnings growth; (ii) a proxy to the buoyant global FPSO market; and (iii) good exposure to the lucrative Caspian Sea O&G market.
|
Other Calls
|
||
|
||
Economy � ASEAN outlook � Weekly Wrap (24 � 28 March 2014)
Asean�s IPI and exports likely to improve in February
|
||
|
||
|
For
important disclosures, please refer to the Disclosure section at the end of
the individual linked research reports. |
Unsubscribe
You are currently subscribed to receive this email newsletter daily. If you no longer want to receive our email newsletter - Go here to unsubscribe and we will promptly remove you from our mailing list. |
|
Privacy
Affin Investment Bank Berhad respects your privacy and is committed to protecting the confidentiality and security of personal information provided to us. We will not use your personal information in this email newsletter or sell your email address to a third party. Go here to contact us. We welcome questions about our use of your personal information provided to us, or your comments about information that you would like to see incorporated in this newsletter. |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.